Retinoblastoma in transgenic mice: Models of hereditary retinoblastoma

Monte D. Mills, Jolene J. Windle, Daniel Albert

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Retinoblastoma, the most common intraocular malignancy in childhood, has served as a paradigm for the study of genetic mechanisms of oncogenesis. The retinoblastoma susceptibility gene RBI was the first tumor suppressor gene to be cloned, and genetic and molecular biologic studies of this tumor have greatly expanded the understanding of the mechanics of tumorigenesis. Human retinoblastoma has essentially no naturally occurring animal counterpart. The development of transgenic murine models of retinoblastoma have created an experimental tool for manipulation of a tumor gene system in vivo. These models have also enabled studies of new therapeutic modalities. This review outlines the development of the transgenic murine models of retinoblastoma, together with the genetic mechanisms of retinoblastoma origin. Current therapeutic innovations developed by means of the transgenic models are described.

Original languageEnglish (US)
Pages (from-to)508-518
Number of pages11
JournalSurvey of Ophthalmology
Volume43
Issue number6
DOIs
StatePublished - May 1 1999
Externally publishedYes

Fingerprint

Retinoblastoma
Transgenic Mice
Carcinogenesis
Retinoblastoma Genes
Neoplasms
Mechanics
Tumor Suppressor Genes
Molecular Biology
Therapeutics
Genes

Keywords

  • Animal models
  • Oncogenes
  • RB1, p53
  • Retinoblastoma
  • Transgenic mice
  • Tumor suppressor genes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Retinoblastoma in transgenic mice : Models of hereditary retinoblastoma. / Mills, Monte D.; Windle, Jolene J.; Albert, Daniel.

In: Survey of Ophthalmology, Vol. 43, No. 6, 01.05.1999, p. 508-518.

Research output: Contribution to journalReview article

Mills, Monte D. ; Windle, Jolene J. ; Albert, Daniel. / Retinoblastoma in transgenic mice : Models of hereditary retinoblastoma. In: Survey of Ophthalmology. 1999 ; Vol. 43, No. 6. pp. 508-518.
@article{ac34737b33d14b729223b364477d8bd0,
title = "Retinoblastoma in transgenic mice: Models of hereditary retinoblastoma",
abstract = "Retinoblastoma, the most common intraocular malignancy in childhood, has served as a paradigm for the study of genetic mechanisms of oncogenesis. The retinoblastoma susceptibility gene RBI was the first tumor suppressor gene to be cloned, and genetic and molecular biologic studies of this tumor have greatly expanded the understanding of the mechanics of tumorigenesis. Human retinoblastoma has essentially no naturally occurring animal counterpart. The development of transgenic murine models of retinoblastoma have created an experimental tool for manipulation of a tumor gene system in vivo. These models have also enabled studies of new therapeutic modalities. This review outlines the development of the transgenic murine models of retinoblastoma, together with the genetic mechanisms of retinoblastoma origin. Current therapeutic innovations developed by means of the transgenic models are described.",
keywords = "Animal models, Oncogenes, RB1, p53, Retinoblastoma, Transgenic mice, Tumor suppressor genes",
author = "Mills, {Monte D.} and Windle, {Jolene J.} and Daniel Albert",
year = "1999",
month = "5",
day = "1",
doi = "10.1016/S0039-6257(99)00047-8",
language = "English (US)",
volume = "43",
pages = "508--518",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Retinoblastoma in transgenic mice

T2 - Models of hereditary retinoblastoma

AU - Mills, Monte D.

AU - Windle, Jolene J.

AU - Albert, Daniel

PY - 1999/5/1

Y1 - 1999/5/1

N2 - Retinoblastoma, the most common intraocular malignancy in childhood, has served as a paradigm for the study of genetic mechanisms of oncogenesis. The retinoblastoma susceptibility gene RBI was the first tumor suppressor gene to be cloned, and genetic and molecular biologic studies of this tumor have greatly expanded the understanding of the mechanics of tumorigenesis. Human retinoblastoma has essentially no naturally occurring animal counterpart. The development of transgenic murine models of retinoblastoma have created an experimental tool for manipulation of a tumor gene system in vivo. These models have also enabled studies of new therapeutic modalities. This review outlines the development of the transgenic murine models of retinoblastoma, together with the genetic mechanisms of retinoblastoma origin. Current therapeutic innovations developed by means of the transgenic models are described.

AB - Retinoblastoma, the most common intraocular malignancy in childhood, has served as a paradigm for the study of genetic mechanisms of oncogenesis. The retinoblastoma susceptibility gene RBI was the first tumor suppressor gene to be cloned, and genetic and molecular biologic studies of this tumor have greatly expanded the understanding of the mechanics of tumorigenesis. Human retinoblastoma has essentially no naturally occurring animal counterpart. The development of transgenic murine models of retinoblastoma have created an experimental tool for manipulation of a tumor gene system in vivo. These models have also enabled studies of new therapeutic modalities. This review outlines the development of the transgenic murine models of retinoblastoma, together with the genetic mechanisms of retinoblastoma origin. Current therapeutic innovations developed by means of the transgenic models are described.

KW - Animal models

KW - Oncogenes

KW - RB1, p53

KW - Retinoblastoma

KW - Transgenic mice

KW - Tumor suppressor genes

UR - http://www.scopus.com/inward/record.url?scp=0032778395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032778395&partnerID=8YFLogxK

U2 - 10.1016/S0039-6257(99)00047-8

DO - 10.1016/S0039-6257(99)00047-8

M3 - Review article

C2 - 10416793

AN - SCOPUS:0032778395

VL - 43

SP - 508

EP - 518

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 6

ER -